Metriport, a health data infrastructure company, has secured $26 million in new funding to help clinicians access structured and comprehensive patient information at the point of care. The investment round was led by TJ Parker, general partner at Matrix, with participation from ARTIS and Y Combinator. The announcement brings Metriport's total funding to $28.4 million and supports the expansion of its open-source platform used by organizations such as Amazon One Medical, Sollis Health, and Color Health.
The Funding Round and Its Backers
The round was led by TJ Parker, general partner at Matrix, who noted that leading consumer health companies increasingly rely on Metriport. Parker praised the team's technical execution, customer service, and compliance rigor as distinguishing qualities in a competitive field. Existing investors ARTIS and Y Combinator also joined the financing, reinforcing confidence in the company's approach.
Closing the Gap in Patient Data
Healthcare providers still struggle to assemble complete patient histories because records arrive in inconsistent formats from disconnected sources. In many cases, staff submit requests to outside facilities and wait weeks while patients attempt to recall their own medical details. This inefficiency leads to administrative waste, duplicate tests, incomplete diagnoses, and delayed treatment.
Unified Platform Response
Metriport addresses this challenge by handling both data aggregation and the extraction of relevant clinical information. The platform connects to dozens of major healthcare data sources and applies matching, extraction, standardization, deduplication, and enrichment to records. Regardless of original structure, data is converted into a unified model and made accessible through a single API, data warehouse, or applications directly within an electronic health record.
Real-Time Alerts and AI Summarization
The platform also keeps providers informed with real-time alerts as patients move through the healthcare system. AI-powered medical record summarization sits on top of the standardized data to help clinicians quickly identify what is relevant during a visit. This combination of access, enrichment, and insight is designed to drive better outcomes without requiring a data science background.
Clinical Impact at Sollis Health
At Sollis Health, physicians use Metriport to access complete outside records and surface insights that were previously unavailable. Dr. Scott Braunstein, Chief Medical Officer at Sollis Health, explained that missing histories often forced repeat tests or unnecessary hospital transfers. In one case, the platform located an operative report showing an early ulcer for a patient with upper abdominal pain, allowing immediate treatment without a new CT scan.
Open-Source Infrastructure and Security
Metriport's open-source model is intended to bring transparency to how patient information is managed and transformed. Chief Operating Officer and co-founder Colin Elsinga emphasized that usable longitudinal patient data forms the foundation for downstream technologies, including artificial intelligence. The company recently achieved HITRUST r2 Certification, and it applies rigorous vetting to every prospective customer before granting access to healthcare data exchange networks.
Future Plans and Responsible Access
The new capital will support platform scaling and the expansion of AI, machine learning, and agentic capabilities. Metriport also plans to maintain its focus on engineering rigor and customer value as usage of health information exchange grows. General Counsel Matt Davis-Ratner said the company conducts deep diligence on every organization seeking access to exchange networks because healthcare data demands the highest level of protection.
Metriport's latest funding round reflects growing demand for reliable health data infrastructure at a time when interoperability remains incomplete. By combining open-source development with security, compliance, and practical clinical tools, the company aims to reduce wasted time and improve care decisions. Chief Executive Officer and co-founder Dima Goncharov argued that patients and providers should expect decisions to be made with full health context, and Metriport invites the industry to build toward that standard.